• Doctorate degree in biology at the University of Karlsruhe/D, KIT Botanical Institute for Molecular Biology and Biochemistry, Prof. Hartmut K. Lichtenthaler

  • Post Doc, Yale University/USA, Biological and Biomedical Sciences (BBS): Plant Molecular Biology. Prof. Stephen L. Dellaporta

  • Profit by Difference Coach® with training under Dr. Peter Modler


Senior Director Business & Medical Affairs, QIAGEN,

Team Leading Function (11 FTE)
Business Ownership for the Oncology Portfolio, > 50 M$
Business Product Marketing and Product Portfolio Management for the MDX Oncology Assay & NGS Business
GTM responsibility with full commercial accountability Leading the Biomarker team


Director Market Development & Business Strategy, THERMO FISHER SCIENTIFIC

Global Responsibilities, Team Leading Function (12 FTE)
Building new product concept – community panel program, enabling to launch RUO clinical content
Building a new product development process – via KOL/Falcon Developer networks
Building a new GTM process to drive local acceptance according to local accreditation requirements; 40 – 60% market penetration within the first 12 month after product launch


Senior Manager Application Support, APPLIED BIOSYSTEMS

European Responsibilities, Team Leading Function (7 FTE)
Drive NPS and customer intimacy index up to above 65% by building knowledge centers within the Fields Application Force


Member of the Scientific Advisory Board of APPLIED BIOSYSTEMS

Responsible to develop the 5–10 year scientific vision of the company
Recommendation for M&A
Collaboration with the Board of Directors on scientific and technical vision


The Gene Reader System

First complete next generation sequencing offering in the clinical segment. From individual device to system solution: Core strategy for repositioning in an already occupied market segment.


Proof of Principle

EHEC breakout in Germany 2011: Use case demonstration under emergency conditions.


The Falcon Team

Disruptive innovation in clinical everyday 2011–2013. From technical innovation to clinically usable solution. Development of a new product development and go-to-market concept.


Pre-implantation diagnostics/ Ion Torrent PGM®

How new business fields can arise from technology trends.


STUDIES and further links

McKinsey report – Woman matter, Jan 2008

McKinsey report – Delivering trough diversity, Jan 2018


Nice to hear from you!



Am Erlenbach 6
88662 Überlingen

Web: www.emc2lc.de
Email: sg@emc2lc.de

Phone: +49 7551 97 06 71
Mobile: +49 176 82 20 66 11